Key facts
- This page summarizes Tamer I. Khayal's Form 4 filing for TransMedics Group, Inc. (TMDX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 26 Feb 2025, 18:07.
Tamer I. Khayal - 24 Feb 2025 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- TMDX
- Reported as of
- 24 Feb 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 26 Feb 2025, 18:07:19 UTC
- Prior SEC filing
- 10 Jan 2025
- Next SEC filing
- 05 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Gerardo Hernandez, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Tamer I. Khayal filed Form 4 for TransMedics Group, Inc. (TMDX) on 26 Feb 2025.
Change
- Previous filing in this sequence was filed on 10 Jan 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TMDX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +17,606
- Change %
- +84%
- Price
- $0.000000
- Shares after
- 38,449
- Date
- 24 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TMDX
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +26,499
- Change %
- Price
- $0.000000
- Shares after
- 26,499
- Date
- 24 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 26,499
- Exercise price
- $77.12
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Consists of 17,606 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Footnote F2
The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service.